Market Analysis and Insights: Global Blood Transfusion Diagnostics Market
The research report studies the Blood Transfusion Diagnostics market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Blood Transfusion Diagnostics market size is projected to reach US$ 4338.7 million by 2027, from US$ 3034.7 million in 2020, at a CAGR of 4.8% during 2021-2027.
Global Blood Transfusion Diagnostics Scope and Segment
The global Blood Transfusion Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Blood Transfusion Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
by Type, the market is primarily split into
ELISA
NAT
Western Blot Assays
Fluorescence Assay
Other Technology
by Application, this report covers the following segments
Hospitals
Clinics
Blood Banks
Laboratories
Other
Global Blood Transfusion Diagnostics market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Blood Transfusion Diagnostics key players in this market include:
Grifols
Thermo Fisher Scientific
Roche
bioMérieux
Bio-Rad
Ortho Clinical Diagnostics
Becton Dickinson
Fujirebio
DiaSorin(American Standard Companies)
Beckman Coulter
Diagast
Abbott
BAG Health Care
Quidel
The research report studies the Blood Transfusion Diagnostics market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Blood Transfusion Diagnostics market size is projected to reach US$ 4338.7 million by 2027, from US$ 3034.7 million in 2020, at a CAGR of 4.8% during 2021-2027.
Global Blood Transfusion Diagnostics Scope and Segment
The global Blood Transfusion Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Blood Transfusion Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
by Type, the market is primarily split into
ELISA
NAT
Western Blot Assays
Fluorescence Assay
Other Technology
by Application, this report covers the following segments
Hospitals
Clinics
Blood Banks
Laboratories
Other
Global Blood Transfusion Diagnostics market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Blood Transfusion Diagnostics key players in this market include:
Grifols
Thermo Fisher Scientific
Roche
bioMérieux
Bio-Rad
Ortho Clinical Diagnostics
Becton Dickinson
Fujirebio
DiaSorin(American Standard Companies)
Beckman Coulter
Diagast
Abbott
BAG Health Care
Quidel
1 Market Overview of Blood Transfusion Diagnostics
1.1 Blood Transfusion Diagnostics Market Overview
1.1.1 Blood Transfusion Diagnostics Product Scope
1.1.2 Blood Transfusion Diagnostics Market Status and Outlook
1.2 Global Blood Transfusion Diagnostics Market Size Overview by Region 2016 VS 2021VS 2027
1.3 Global Blood Transfusion Diagnostics Market Size by Region (2016-2027)
1.4 Global Blood Transfusion Diagnostics Historic Market Size by Region (2016-2021)
1.5 Global Blood Transfusion Diagnostics Market Size Forecast by Region (2022-2027)
1.6 Key Regions, Blood Transfusion Diagnostics Market Size (2016-2027)
1.6.1 North America Blood Transfusion Diagnostics Market Size (2016-2027)
1.6.2 Europe Blood Transfusion Diagnostics Market Size (2016-2027)
1.6.3 Asia-Pacific Blood Transfusion Diagnostics Market Size (2016-2027)
1.6.4 Latin America Blood Transfusion Diagnostics Market Size (2016-2027)
1.6.5 Middle East & Africa Blood Transfusion Diagnostics Market Size (2016-2027)
2 Blood Transfusion Diagnostics Market Overview by Type
2.1 Global Blood Transfusion Diagnostics Market Size by Type: 2016 VS 2021 VS 2027
2.2 Global Blood Transfusion Diagnostics Historic Market Size by Type (2016-2021)
2.3 Global Blood Transfusion Diagnostics Forecasted Market Size by Type (2022-2027)
2.4 ELISA
2.5 NAT
2.6 Western Blot Assays
2.7 Fluorescence Assay
2.8 Other Technology
3 Blood Transfusion Diagnostics Market Overview by Application
3.1 Global Blood Transfusion Diagnostics Market Size by Application: 2016 VS 2021 VS 2027
3.2 Global Blood Transfusion Diagnostics Historic Market Size by Application (2016-2021)
3.3 Global Blood Transfusion Diagnostics Forecasted Market Size by Application (2022-2027)
3.4 Hospitals
3.5 Clinics
3.6 Blood Banks
3.7 Laboratories
3.8 Other
4 Blood Transfusion Diagnostics Competition Analysis by Players
4.1 Global Blood Transfusion Diagnostics Market Size by Players (2016-2021)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Blood Transfusion Diagnostics as of 2020)
4.3 Date of Key Players Enter into Blood Transfusion Diagnostics Market
4.4 Global Top Players Blood Transfusion Diagnostics Headquarters and Area Served
4.5 Key Players Blood Transfusion Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Blood Transfusion Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Grifols
5.1.1 Grifols Profile
5.1.2 Grifols Main Business
5.1.3 Grifols Blood Transfusion Diagnostics Products, Services and Solutions
5.1.4 Grifols Blood Transfusion Diagnostics Revenue (US$ Million) & (2016-2021)
5.1.5 Grifols Recent Developments
5.2 Thermo Fisher Scientific
5.2.1 Thermo Fisher Scientific Profile
5.2.2 Thermo Fisher Scientific Main Business
5.2.3 Thermo Fisher Scientific Blood Transfusion Diagnostics Products, Services and Solutions
5.2.4 Thermo Fisher Scientific Blood Transfusion Diagnostics Revenue (US$ Million) & (2016-2021)
5.2.5 Thermo Fisher Scientific Recent Developments
5.3 Roche
5.3.1 Roche Profile
5.3.2 Roche Main Business
5.3.3 Roche Blood Transfusion Diagnostics Products, Services and Solutions
5.3.4 Roche Blood Transfusion Diagnostics Revenue (US$ Million) & (2016-2021)
5.3.5 bioMérieux Recent Developments
5.4 bioMérieux
5.4.1 bioMérieux Profile
5.4.2 bioMérieux Main Business
5.4.3 bioMérieux Blood Transfusion Diagnostics Products, Services and Solutions
5.4.4 bioMérieux Blood Transfusion Diagnostics Revenue (US$ Million) & (2016-2021)
5.4.5 bioMérieux Recent Developments
5.5 Bio-Rad
5.5.1 Bio-Rad Profile
5.5.2 Bio-Rad Main Business
5.5.3 Bio-Rad Blood Transfusion Diagnostics Products, Services and Solutions
5.5.4 Bio-Rad Blood Transfusion Diagnostics Revenue (US$ Million) & (2016-2021)
5.5.5 Bio-Rad Recent Developments
5.6 Ortho Clinical Diagnostics
5.6.1 Ortho Clinical Diagnostics Profile
5.6.2 Ortho Clinical Diagnostics Main Business
5.6.3 Ortho Clinical Diagnostics Blood Transfusion Diagnostics Products, Services and Solutions
5.6.4 Ortho Clinical Diagnostics Blood Transfusion Diagnostics Revenue (US$ Million) & (2016-2021)
5.6.5 Ortho Clinical Diagnostics Recent Developments
5.7 Becton Dickinson
5.7.1 Becton Dickinson Profile
5.7.2 Becton Dickinson Main Business
5.7.3 Becton Dickinson Blood Transfusion Diagnostics Products, Services and Solutions
5.7.4 Becton Dickinson Blood Transfusion Diagnostics Revenue (US$ Million) & (2016-2021)
5.7.5 Becton Dickinson Recent Developments
5.8 Fujirebio
5.8.1 Fujirebio Profile
5.8.2 Fujirebio Main Business
5.8.3 Fujirebio Blood Transfusion Diagnostics Products, Services and Solutions
5.8.4 Fujirebio Blood Transfusion Diagnostics Revenue (US$ Million) & (2016-2021)
5.8.5 Fujirebio Recent Developments
5.9 DiaSorin(American Standard Companies)
5.9.1 DiaSorin(American Standard Companies) Profile
5.9.2 DiaSorin(American Standard Companies) Main Business
5.9.3 DiaSorin(American Standard Companies) Blood Transfusion Diagnostics Products, Services and Solutions
5.9.4 DiaSorin(American Standard Companies) Blood Transfusion Diagnostics Revenue (US$ Million) & (2016-2021)
5.9.5 DiaSorin(American Standard Companies) Recent Developments
5.10 Beckman Coulter
5.10.1 Beckman Coulter Profile
5.10.2 Beckman Coulter Main Business
5.10.3 Beckman Coulter Blood Transfusion Diagnostics Products, Services and Solutions
5.10.4 Beckman Coulter Blood Transfusion Diagnostics Revenue (US$ Million) & (2016-2021)
5.10.5 Beckman Coulter Recent Developments
5.11 Diagast
5.11.1 Diagast Profile
5.11.2 Diagast Main Business
5.11.3 Diagast Blood Transfusion Diagnostics Products, Services and Solutions
5.11.4 Diagast Blood Transfusion Diagnostics Revenue (US$ Million) & (2016-2021)
5.11.5 Diagast Recent Developments
5.12 Abbott
5.12.1 Abbott Profile
5.12.2 Abbott Main Business
5.12.3 Abbott Blood Transfusion Diagnostics Products, Services and Solutions
5.12.4 Abbott Blood Transfusion Diagnostics Revenue (US$ Million) & (2016-2021)
5.12.5 Abbott Recent Developments
5.13 BAG Health Care
5.13.1 BAG Health Care Profile
5.13.2 BAG Health Care Main Business
5.13.3 BAG Health Care Blood Transfusion Diagnostics Products, Services and Solutions
5.13.4 BAG Health Care Blood Transfusion Diagnostics Revenue (US$ Million) & (2016-2021)
5.13.5 BAG Health Care Recent Developments
5.14 Quidel
5.14.1 Quidel Profile
5.14.2 Quidel Main Business
5.14.3 Quidel Blood Transfusion Diagnostics Products, Services and Solutions
5.14.4 Quidel Blood Transfusion Diagnostics Revenue (US$ Million) & (2016-2021)
5.14.5 Quidel Recent Developments
6 North America
6.1 North America Blood Transfusion Diagnostics Market Size by Country (2016-2027)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Blood Transfusion Diagnostics Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Blood Transfusion Diagnostics Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Blood Transfusion Diagnostics Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Blood Transfusion Diagnostics Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Blood Transfusion Diagnostics Market Dynamics
11.1 Blood Transfusion Diagnostics Industry Trends
11.2 Blood Transfusion Diagnostics Market Drivers
11.3 Blood Transfusion Diagnostics Market Challenges
11.4 Blood Transfusion Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
1.1 Blood Transfusion Diagnostics Market Overview
1.1.1 Blood Transfusion Diagnostics Product Scope
1.1.2 Blood Transfusion Diagnostics Market Status and Outlook
1.2 Global Blood Transfusion Diagnostics Market Size Overview by Region 2016 VS 2021VS 2027
1.3 Global Blood Transfusion Diagnostics Market Size by Region (2016-2027)
1.4 Global Blood Transfusion Diagnostics Historic Market Size by Region (2016-2021)
1.5 Global Blood Transfusion Diagnostics Market Size Forecast by Region (2022-2027)
1.6 Key Regions, Blood Transfusion Diagnostics Market Size (2016-2027)
1.6.1 North America Blood Transfusion Diagnostics Market Size (2016-2027)
1.6.2 Europe Blood Transfusion Diagnostics Market Size (2016-2027)
1.6.3 Asia-Pacific Blood Transfusion Diagnostics Market Size (2016-2027)
1.6.4 Latin America Blood Transfusion Diagnostics Market Size (2016-2027)
1.6.5 Middle East & Africa Blood Transfusion Diagnostics Market Size (2016-2027)
2 Blood Transfusion Diagnostics Market Overview by Type
2.1 Global Blood Transfusion Diagnostics Market Size by Type: 2016 VS 2021 VS 2027
2.2 Global Blood Transfusion Diagnostics Historic Market Size by Type (2016-2021)
2.3 Global Blood Transfusion Diagnostics Forecasted Market Size by Type (2022-2027)
2.4 ELISA
2.5 NAT
2.6 Western Blot Assays
2.7 Fluorescence Assay
2.8 Other Technology
3 Blood Transfusion Diagnostics Market Overview by Application
3.1 Global Blood Transfusion Diagnostics Market Size by Application: 2016 VS 2021 VS 2027
3.2 Global Blood Transfusion Diagnostics Historic Market Size by Application (2016-2021)
3.3 Global Blood Transfusion Diagnostics Forecasted Market Size by Application (2022-2027)
3.4 Hospitals
3.5 Clinics
3.6 Blood Banks
3.7 Laboratories
3.8 Other
4 Blood Transfusion Diagnostics Competition Analysis by Players
4.1 Global Blood Transfusion Diagnostics Market Size by Players (2016-2021)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Blood Transfusion Diagnostics as of 2020)
4.3 Date of Key Players Enter into Blood Transfusion Diagnostics Market
4.4 Global Top Players Blood Transfusion Diagnostics Headquarters and Area Served
4.5 Key Players Blood Transfusion Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Blood Transfusion Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Grifols
5.1.1 Grifols Profile
5.1.2 Grifols Main Business
5.1.3 Grifols Blood Transfusion Diagnostics Products, Services and Solutions
5.1.4 Grifols Blood Transfusion Diagnostics Revenue (US$ Million) & (2016-2021)
5.1.5 Grifols Recent Developments
5.2 Thermo Fisher Scientific
5.2.1 Thermo Fisher Scientific Profile
5.2.2 Thermo Fisher Scientific Main Business
5.2.3 Thermo Fisher Scientific Blood Transfusion Diagnostics Products, Services and Solutions
5.2.4 Thermo Fisher Scientific Blood Transfusion Diagnostics Revenue (US$ Million) & (2016-2021)
5.2.5 Thermo Fisher Scientific Recent Developments
5.3 Roche
5.3.1 Roche Profile
5.3.2 Roche Main Business
5.3.3 Roche Blood Transfusion Diagnostics Products, Services and Solutions
5.3.4 Roche Blood Transfusion Diagnostics Revenue (US$ Million) & (2016-2021)
5.3.5 bioMérieux Recent Developments
5.4 bioMérieux
5.4.1 bioMérieux Profile
5.4.2 bioMérieux Main Business
5.4.3 bioMérieux Blood Transfusion Diagnostics Products, Services and Solutions
5.4.4 bioMérieux Blood Transfusion Diagnostics Revenue (US$ Million) & (2016-2021)
5.4.5 bioMérieux Recent Developments
5.5 Bio-Rad
5.5.1 Bio-Rad Profile
5.5.2 Bio-Rad Main Business
5.5.3 Bio-Rad Blood Transfusion Diagnostics Products, Services and Solutions
5.5.4 Bio-Rad Blood Transfusion Diagnostics Revenue (US$ Million) & (2016-2021)
5.5.5 Bio-Rad Recent Developments
5.6 Ortho Clinical Diagnostics
5.6.1 Ortho Clinical Diagnostics Profile
5.6.2 Ortho Clinical Diagnostics Main Business
5.6.3 Ortho Clinical Diagnostics Blood Transfusion Diagnostics Products, Services and Solutions
5.6.4 Ortho Clinical Diagnostics Blood Transfusion Diagnostics Revenue (US$ Million) & (2016-2021)
5.6.5 Ortho Clinical Diagnostics Recent Developments
5.7 Becton Dickinson
5.7.1 Becton Dickinson Profile
5.7.2 Becton Dickinson Main Business
5.7.3 Becton Dickinson Blood Transfusion Diagnostics Products, Services and Solutions
5.7.4 Becton Dickinson Blood Transfusion Diagnostics Revenue (US$ Million) & (2016-2021)
5.7.5 Becton Dickinson Recent Developments
5.8 Fujirebio
5.8.1 Fujirebio Profile
5.8.2 Fujirebio Main Business
5.8.3 Fujirebio Blood Transfusion Diagnostics Products, Services and Solutions
5.8.4 Fujirebio Blood Transfusion Diagnostics Revenue (US$ Million) & (2016-2021)
5.8.5 Fujirebio Recent Developments
5.9 DiaSorin(American Standard Companies)
5.9.1 DiaSorin(American Standard Companies) Profile
5.9.2 DiaSorin(American Standard Companies) Main Business
5.9.3 DiaSorin(American Standard Companies) Blood Transfusion Diagnostics Products, Services and Solutions
5.9.4 DiaSorin(American Standard Companies) Blood Transfusion Diagnostics Revenue (US$ Million) & (2016-2021)
5.9.5 DiaSorin(American Standard Companies) Recent Developments
5.10 Beckman Coulter
5.10.1 Beckman Coulter Profile
5.10.2 Beckman Coulter Main Business
5.10.3 Beckman Coulter Blood Transfusion Diagnostics Products, Services and Solutions
5.10.4 Beckman Coulter Blood Transfusion Diagnostics Revenue (US$ Million) & (2016-2021)
5.10.5 Beckman Coulter Recent Developments
5.11 Diagast
5.11.1 Diagast Profile
5.11.2 Diagast Main Business
5.11.3 Diagast Blood Transfusion Diagnostics Products, Services and Solutions
5.11.4 Diagast Blood Transfusion Diagnostics Revenue (US$ Million) & (2016-2021)
5.11.5 Diagast Recent Developments
5.12 Abbott
5.12.1 Abbott Profile
5.12.2 Abbott Main Business
5.12.3 Abbott Blood Transfusion Diagnostics Products, Services and Solutions
5.12.4 Abbott Blood Transfusion Diagnostics Revenue (US$ Million) & (2016-2021)
5.12.5 Abbott Recent Developments
5.13 BAG Health Care
5.13.1 BAG Health Care Profile
5.13.2 BAG Health Care Main Business
5.13.3 BAG Health Care Blood Transfusion Diagnostics Products, Services and Solutions
5.13.4 BAG Health Care Blood Transfusion Diagnostics Revenue (US$ Million) & (2016-2021)
5.13.5 BAG Health Care Recent Developments
5.14 Quidel
5.14.1 Quidel Profile
5.14.2 Quidel Main Business
5.14.3 Quidel Blood Transfusion Diagnostics Products, Services and Solutions
5.14.4 Quidel Blood Transfusion Diagnostics Revenue (US$ Million) & (2016-2021)
5.14.5 Quidel Recent Developments
6 North America
6.1 North America Blood Transfusion Diagnostics Market Size by Country (2016-2027)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Blood Transfusion Diagnostics Market Size by Country (2016-2027)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Blood Transfusion Diagnostics Market Size by Region (2016-2027)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Blood Transfusion Diagnostics Market Size by Country (2016-2027)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Blood Transfusion Diagnostics Market Size by Country (2016-2027)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Blood Transfusion Diagnostics Market Dynamics
11.1 Blood Transfusion Diagnostics Industry Trends
11.2 Blood Transfusion Diagnostics Market Drivers
11.3 Blood Transfusion Diagnostics Market Challenges
11.4 Blood Transfusion Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
